3,5-Diphenyl-7-hydroxy-2-methyl-pyrazolo[1,5-a]-pyrimidine, 250mg

3,4-Dihydro-8-methoxynaphthalen-1(2H)-one, 95.0%, 250mg

n-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)formamide, 95+%, 250mg

2,5-DIAZASPIRO[3.4]OCTAN-6-ONE HCL, 95.0%, 500mg

2-Chloro-4-iodobenzoic acid, 98.0%, 25g

1,2-O-Isopropylidene-alpha-D-glucofuranose, 95.0%, 100g

N-(5-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PYRIDIN-2-YL)-2,5-DIOXO-1-PHENYL-1,2,5,6,7,8-HEXAHYDROQUINOLINE-3-CARBOXAMIDE, 95%, 50mg

1,2-Bis(4-chlorophenyl)diazene, 95.0%, 100mg

4-(chloromethyl)-2-(2-methylphenyl)-1,3-thiazole, 95.0%, 5g

L-3,4-Difluorophenylalanine, 95.0%, 1g

Fexofenadine Hydrochloride, >98.0%(HPLC)(T), 1mg

Aluminum acetate, basic hydrate, min. 98%, pure, 500 g, plastic packaging.

N-(1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyloxycarbonyl-1,8-diamino-3,6-dioxaoctane>90.0%(HPLC)25mg